NASDAQ:ABCL

Abcellera Biologics Stock Predictions

Healthcare > Biotechnology

Buy ABCL

*Your capital is at risk

$5.72

-0.410 (-6.69%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

ABCL Prediction Chart

ABCL Predictions History

Latest community submissions for ABCL.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
viktor.jursis.351627	Dec 30, 2022	Bullish	$10.13	V	—	1
gertschepens.338211	Aug 19, 2022	$13.00 +4.42%	$11.44	X	86.36%	0
darkblood40k.328601	Jun 8, 2022	$18.00 +134.68% Unrealistic Excluded from avg	$7.96	V	0.00%	1
JS Pro	Jan 24, 2022	$8.30 -3.15%	$8.57	X	96.85%	1
UncleSam	Jan 24, 2022	$9.20 +7.35%	$8.57	X	92.65%	0
JS Pro	Apr 1, 2021	$35.61 +15.96%	$30.71	X	84.04%	0
cmgn616	Apr 1, 2021	$40.00 +30.25%	$30.71	X	69.75%	1

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ABCL with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT ABCELLERA BIOLOGICS INC.

AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in progress, or under contract with 36 partners. AbCellera Biologics Inc. has a research collaboration and...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
RUN $12.83	18.86%	May 06
GLBE $31.61	5.35%	May 05
SAP $172.39	10.69%	May 05
W WCLD $27.34	27.18%	Apr 29
ADBE $243.57	7.61%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by